Methoxamine Hydrochloride

CHEMBL1201103 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
247.7 g/mol
LogP
Phase
4

A hydrochloride salt form of methoxamine, a vasopressor used to treat low blood pressure during anesthesia.

Khối lượng phân tử

247,7200 g/mol

TPSA

64,70 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1ccc(OC)c(C(O)C(C)N)c1.Cl

InChI

InChI=1S/C11H17NO3.ClH/c1-7(12)11(13)9-6-8(14-2)4-5-10(9)15-3;/h4-7,11,13H,12H2,1-3H3;1H

Molecular Formula

C11H18ClNO3

HBD / HBA

3 / 4

Liên kết có thể quay

4

Nguyên tử nặng

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A hydrochloride salt form of methoxamine, a vasopressor used to treat low blood pressure during anesthesia.

Yes, Methoxamine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201103. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 57333099. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.